| Financial Year |
March 31 2023 |
| Monetary Funds |
204,759,330.06 |
| Held-for-trading Financial Assets |
619,554,015.22 |
| Notes Receivable |
14,042,620.85 |
| Accounts Receivable |
183,277,393.78 |
| Advances to Suppliers |
8,699,688.77 |
| Other Receivables |
8,688,273.42 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
156,762,107.37 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,593,334.32 |
| Total Current Assets |
1,207,100,328.19 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
80,112,364.89 |
| Investment Properties |
-- |
| Fixed Assetes |
941,389,670.86 |
| Under-construction Projects |
94,970,203.47 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
83,638,363.49 |
| R&D expenses |
-- |
| Goodwill |
8,766,208.59 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
10,385,110.19 |
| Other Non-Current Assets |
5,902,827.23 |
| Sub-Total of Non-Current Assets |
1,225,164,748.72 |
| Total Assets |
2,432,265,076.91 |
| Short-Term Loans |
10,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
196,416,840.18 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
30,039,417.19 |
| Taxes Payable |
3,631,641.06 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
7,124,316.35 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
13,022,015.95 |
| Sub-Total of Current Liabilities |
278,423,611.19 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
25,321,808.27 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
35,770,105.72 |
| Total Liabilities |
314,193,716.91 |
| Paid-In Capital(Or Share Stock) |
294,682,500.00 |
| Capital Surplus |
712,777,893.48 |
| Surplus Reserve |
140,732,457.83 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
869,452,768.45 |
| Minority Stockholder's Interest |
84,759,812.77 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,033,311,547.23 |
| Owner's Equity（Stockholder's Equity） |
2,118,071,360.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,432,265,076.91 |
